JORDAN; Craig

Patent Applications and Registrations

Patent applications and USPTO patent grants for JORDAN; Craig.The latest application filed is for "amp-activated protein kinase inhibitors and methods of making and using the same".

Company Profile

2.14.17

JORDAN; Craig - Aurora CO
Jordan; Craig - Lake Villa WI
Jordan; Craig - Fox Lake IL
Jordan; Craig - Webster NY
Jordan; Craig - Denver CO
Jordan; Craig - Rochester NY
Jordan; Craig - Lexington KY US
Jordan; Craig - Madison AL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Amp-activated Protein Kinase Inhibitors And Methods Of Making And Using The Same App 20220289707 - REIGAN; Philip ; et al.	2022-09-15
Data management systems and methods Grant 11,375,693 - Jordan , et al. July 5, 2	2022-07-05
Compositions And Methods For Reducing Cancer Stem Cells App 20210315878 - JORDAN; Craig ; et al.	2021-10-14
Animal motion and temperature monitoring Grant 11,080,495 - Ruiter , et al. August 3, 2	2021-08-03
Animal Motion And Temperature Monitoring App 20200134272 - Ruiter; Matthew ; et al.	2020-04-30
Methods to Impair Hematologic Cancer Progenitor Cells and Compounds Related Thereto App 20200031942 - Jordan; Craig	2020-01-30
Methods to impair hematologic cancer progenitor cells and compounds related thereto Grant 10,508,150 - Jordan Dec	2019-12-17
Triazole derivatives of melampomagnolide B and methods of use thereof Grant 10,428,082 - Janganati , et al. October 1, 2	2019-10-01
Triazole Derivatives Of Melampomagnolide B And Methods Of Use Thereof App 20190040077 - Janganati; Venumadhav ; et al.	2019-02-07
Melampomagnolide B dimers Grant 10,118,935 - Janganati , et al. November 6, 2	2018-11-06
Melampomagnolide B Dimers App 20180237458 - Janganati; Venumadhav ; et al.	2018-08-23
Melampomagnolide B dimers Grant 9,981,990 - Janganati , et al. May 29, 2	2018-05-29
Melampomagnolide B Dimers App 20170362254 - Janganati; Venumadhav ; et al.	2017-12-21
Data Management Systems And Methods App 20170124264 - Jordan; Craig ; et al.	2017-05-04
Thiadiazolidinone Derivatives App 20160058741 - Jordan; Craig ; et al.	2016-03-03
Thiadiazolidinone derivatives Grant 9,180,118 - Jordan , et al. November 10, 2	2015-11-10
Methods To Impair Hematologic Cancer Progenitor Cells And Compounds Related Thereto App 20150132315 - Jordan; Craig	2015-05-14
Methods to impair hematologic cancer progenitor cells and compounds related thereto Grant 8,852,551 - Jordan October 7, 2	2014-10-07
Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof Grant 7,723,019 - Moscow , et al. May 25, 2	2010-05-25
Methods To Impair Hematologic Cancer Progenitor Cells And Compounds Related Thereto App 20100093003 - Jordan; Craig	2010-04-15
Thiadiazolidinone Derivatives App 20100063109 - Jordan; Craig ; et al.	2010-03-11
Methods to impair hematologic cancer progenitor cells and compounds related thereto Grant 7,651,678 - Jordan January 26, 2	2010-01-26
Organic cation transporter preferentially expressed in hematopoietic cells and leukemias and uses thereof App 20070269846 - Moscow; Jeffrey ; et al.	2007-11-22
System and method for analyzing dependence between gene expressions App 20070117132 - Yakovlev; Andrei ; et al.	2007-05-24
Methods to impair hematologic cancer progenitor cells and compounds related thereto App 20040197337 - Jordan, Craig	2004-10-07
System and method for packing and unpacking video data Grant 6,753,874 - Ford , et al. June 22, 2	2004-06-22
Methods to impair hematologic cancer progenitor cells and compounds related thereto Grant 6,733,743 - Jordan May 11, 2	2004-05-11
Methods to impair hematologic cancer progenitor cells and compounds related thereto App 20030039611 - Jordan, Craig	2003-02-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.